Try a new search

Format these results:

Searched for:

person:esping03

in-biosketch:yes

Total Results:

17


Kidney stones (renal calculi, nephrolithiasis)

Chapter by: Espinosa, Geovanni; Murray, Michael T
in: Textbook of natural medicine by Pizzorno, Joseph E; Murray, Michael T (Eds)
St. Louis, Mo. : Elsevier/Churchill Livingstone, 2013
pp. 1564-1573
ISBN: 1437723330
CID: 3122482

Benign Prostatic Hyperplasia

Chapter by: Espinosa, Geovanni; Murray, Michael T
in: Textbook of natural medicine by Pizzorno, Joseph E; Murray, Michael T (Eds)
St. Louis, Mo. : Elsevier/Churchill Livingstone, 2013
pp. 1263-1270
ISBN: 1437723330
CID: 3122462

Cystitis and Interstitial Cystitis/​Painful Bladder Syndrome

Chapter by: Espinosa, Geovanni; Murray, Michael T
in: Textbook of natural medicine by Pizzorno, Joseph E; Murray, Michael T (Eds)
St. Louis, Mo. : Elsevier/Churchill Livingstone, 2013
pp. 1308-1317
ISBN: 1437723330
CID: 3122472

Prostate Cancer Food and Nutrients That May Slow Disease Progression

Chapter by: Espinosa, Geovanni; Quarrier, Scott; Katz, Aaron E
in: ADVANCING MEDICINE WITH FOOD AND NUTRIENTS by
BOCA RATON : CRC PRESS-TAYLOR & FRANCIS GROUP, 2012
pp. 743-759
ISBN:
CID: 1818232

Benign prostatic hyperplasia: current clinical practice

Djavan, Bob; Eckersberger, Elisabeth; Finkelstein, Julia; Espinosa, Geovanni; Sadri, Helen; Brandner, Roland; Shah, Ojas; Lepor, Herbert
Benign prostatic hyperplasia (BPH) is the most common benign adenoma in men, affecting nearly all of them. BPH represents a clinically significant cause of bladder outflow obstruction in up to 40% of men. The growing frequency of diagnosis is due to increasing life expectancy and a trend toward seeking medical advice at earlier stages of the disease. The last decade has witnessed a significant shift in emphasis in the management of BPH, with medical therapies and, to a lesser extent, minimally invasive therapies becoming the predominant active therapy choices. The development of effective therapies such as alpha-adrenergic blockers and 5-alpha-reductase inhibitors and the possibility of their combined use represent the most significant advance in the treatment of BPH
PMID: 20705200
ISSN: 1558-299x
CID: 111970

Complex Mechanisms in Prostatic Inflammatory Response

Djavan, Bob; Eckersberger, Elisabeth; Espinosa, Geovanni; Kramer, Gero; Handisurya, Alessandra; Lee, Chung; Marberger, Michael; Lepor, Herbert; Steiner, Georg E.
Context: The immunology of the prostate has developed into a new field of research in urology. The leukocyte population increases are not yet fully understood, but it has been demonstrated that most resected prostate tissue shows signs of inflammatory response. Objective: This article reviews recent findings and discusses the complex mechanisms involved in the prostatic inflammatory response and the immunologic functions of the prostate, and the roles the prostatic inflammatory response in the cause of prostate disease such as benign prostatic hyperplasia (BPH). Evidence acquisition: We performed a search of the medical literature with PubMed, using keywords such as prostate cancer, inflammation of the prostate, leukocytes, estrogen, and cytokine and genetic expression of inflammation. Articles and data were reviewed as to their relevance, and inclusion and exclusion criteria were determined prospectively. Evidence synthesis: Evidence showing that inflammation of the prostate plays a role in prostate cancer (PCa) is mounting. Different types of inflammation exist and are distinguished according to the distribution and location of leukocytes and the histology of the surrounding tissue. Most resected prostate tissue shows signs of inflammatory response, and a relationship between T-cell infiltration and stromal proliferation can be found. Evidence for the importance of estrogen and proinflammatory cytokine interleukin (IL; IL-6, IL-8, IL-15, IL-17) also can be found. Early stages of investigation of the immunologic function of the prostate show that both prostatic epithelial and stromal cells express members of the toll-like receptor family and are therefore capable of recognizing foreign incoming antigens. Conclusions: Although this area of study is new, the immunology and inflammatory responses of the prostate are seen as important components of further study of prostate diseases such as PCa and BPH. Data supporting the role of immunology and activated leukocytes in malignant cells are also an important finding and can possibly lead to new knowledge about malignant cells. (C) 2009 Published by Elsevier B. V. on behalf of European Association of Urology
ISI:000273406400003
ISSN: 1569-9056
CID: 141042

Prostate Cancer Nutrients That May Slow Its Progression

Chapter by: Katz, Aaron E; Espinosa, Geovanni
in: Food and nutrients in disease management by Kohlstadt, Ingrid [Eds]
Boca Raton : CRC Press, 2009
pp. 639-655
ISBN: 1420067621
CID: 1822702